Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04634045 · ClinicalTrials.gov registry record · NA

Virtual Health Focused Acceptance-Based Program for Parents and Youth

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
19
Enrollment target

NCT04634045: Completed NA study, sponsored by University of Alabama at Birmingham.

NCT04634045 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04634045, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target

Study Summary

The main purpose of vHAPPY is to pilot test a new type of virtual family-based healthy lifestyle program for children aged 8-14 with obesity and their caregivers. vHAPPY aims to (1) Transition a previously developed acceptance-based behavioral treatment to web-based platform, utilizing qualitative and quantitative program evaluation data from past participants. (2) Determine the feasibility, acceptability, and preliminary outcomes of the adapted web-based treatment. (3) Evaluate whether the adapted web-based treatment (self-guided treatment + brief coaching) is similar to the traditional treatment (interventionist-guided treatment) in terms of feasibility, acceptability, and preliminary outcomes utilizing a non-randomized sequential arm design.

Primary Outcome

Semi-structured group interviews will assess caregiver and child experiences with the program.

Interventions

  • BEHAVIORAL Web Based Treatment

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2021-08-01
Est. Completion 2022-02-28
Phase NA
University of Alabama at Birmingham

1,160 total trials

What the finished NCT04634045 record still lists

NCT04634045 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Web Based Treatment is the first listed.

NCT04634045 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04634045 about?

NCT04634045 is a clinical study titled "Virtual Health Focused Acceptance-Based Program for Parents and Youth". The main purpose of vHAPPY is to pilot test a new type of virtual family-based healthy lifestyle program for children aged 8-14 with obesity and their caregivers. vHAPPY aims to (1) Transition a previously developed acceptance-based behavioral treatment to web-based platform, utilizing qualitative a...

What is the current status of trial NCT04634045?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2021-08-01. Estimated completion is 2022-02-28.

What interventions are being tested in trial NCT04634045?

The interventions under investigation include: Web Based Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT04634045?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04634045's enrollment target sits among peer trials

19 1861st of 2000 higher than 138 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03207464 · 19 participants · Phase 1

    Molecular Imaging of NET Using [C-11]MRB-PET in MS

  • NCT04318717 · 19 participants · Phase 2

    Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

  • NCT05103904 · 19 participants · Phase 2

    Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

  • NCT05607407 · 19 participants · Phase 2

    Methimazole in Patients With Progressive Glioblastoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04634045, the US trial registry maintained by the National Library of Medicine. NCT04634045 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.